Roche Holding AG (RHHBF)

Market Cap	227.58B
Revenue (ttm)	67.42B
Net Income (ttm)	11.82B
Shares Out	n/a
EPS (ttm)	14.73
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3
Open	300.50
Previous Close	300.50
Day's Range	300.50 - 300.50
52-Week Range	243.42 - 368.43
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 31, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, d...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1896
• Employees: 103,605
• Stock Exchange: OTCMKTS
• Ticker Symbol: RHHBF

Financial Performance

In 2023, Roche Holding AG's revenue was 60.44 billion, a decrease of -8.16% compared to the previous year's 65.81 billion. Earnings were 11.50 billion, a decrease of -7.43%.

Financial numbers in CHF